From: Readmission rates following heart failure: a scoping review of sex and gender based considerations
Study Characteristics | Type, n |
---|---|
Journal disciplines | Peer-reviewed or double blind, n = 34 Dissertations, n = 2 |
Grey Literature (n = included/potentially eligible) | CADTH- Canadian Agency for Drugs and Technologies in Health n = 0/15 |
Center for Disease Control n.ra. | |
CIHI n.r. | |
Health Canada n = 0/9 | |
Google Scholar n = 1/491 | |
TRIP n = 1/19 | |
National Technical Information Service n = 1/581 | |
Scopus n = 1/10 | |
Duck Duck Go n = 2/200 | |
UofT Theses and Dissertations in the Sciences n = 0 | |
OAIster n = 0/2 | |
Health Quality Ontario, n = 0/5 | |
New York Academy of Medicine’s Grey Literature Report n = 0 | |
Open Grey n = 0/4 | |
T-space n = 0/31 | |
World Health Organization n.r. | |
Consultation Experts | Journal Articles 1/7 (exclusion criteria: did not address re-admission) |
Study Design | Prospective n = 11 |
Retrospective n = 25 | |
Year of publication | 2013–2017 n = 14 |
2008–2012 n = 13 | |
2002–2007 n = 9 | |
Geographical region | North America (US n = 14, Canada n = 4) |
Europe n = 11 | |
Asia n = 4 | |
Australia n = 2 | |
Africa n = 1 |